title: COX-2 inhibitors--first, do no harm.
authors.forename: Mark
authors.initials: M
authors.lastname: Weatherall
authors.forename: Sarah
authors.initials: S
authors.lastname: Aldington
authors.forename: Philippa
authors.initials: P
authors.lastname: Shirtcliffe
authors.forename: Brent
authors.initials: B
authors.lastname: Caldwell
authors.forename: Richard
authors.initials: R
authors.lastname: Beasley
mesh_terms: D002318:Cardiovascular Diseases / Q000139:chemically induced*; D016861:Cyclooxygenase Inhibitors / Q000009:adverse effects* / Q000494:pharmacology; D004335:Drug and Narcotic Control; D006801:Humans; D007783:Lactones / Q000009:adverse effects; D009520:New Zealand; D012306:Risk; D013450:Sulfones / Q000009:adverse effects
chemical_list: D016861:Cyclooxygenase Inhibitors; D007783:Lactones; D013450:Sulfones; C116926:rofecoxib